Subscribe to International
View Sample

FREE Email Newsletter

The European IVF Monitoring Group celebrates its 10-year anniversary

August 4, 2010 6:38 am | by EurekAlert | News | Comments

(European Society of Human Reproduction and Embryology) During this meeting different aspects of ART monitoring in Europe and beyond will be discussed, with an overview over European data, the different registries experiences and possibilities and limitations of pooling data from...

Supply and demand

August 3, 2010 9:38 pm | by EurekAlert | News | Comments

(European Molecular Biology Laboratory) In a study published today in Cell Metabolism, scientists at the European Molecular Biology Laboratory in Heidelberg, Germany, have discovered that a group of proteins called IRPs ensure that iron balance is kept and as such are essential for...

Smoking, nipple piercing are risk factors for developing breast abscesses

August 3, 2010 4:40 pm | by EurekAlert | News | Comments

(Weber Shandwick Worldwide) Women who smoke or pierce their nipples are more likely to develop a breast abscess, according to a new study in the July issue of the Journal of the American College of Surgeons. Researchers at the University of Iowa found the odds of developing primary...


Company decision to pull diabetes drug could add £9 million to NHS drugs bill

August 3, 2010 4:40 pm | by EurekAlert | News | Comments

(BMJ-British Medical Journal) Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add £9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics Bulletin.

ArQule lung cancer treatment one step closer to market

August 3, 2010 10:40 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Woburn-based biotech ArQule Inc. and New Jersey pharmaceutical firm Daiichi Sankyo Co. Ltd. are heading toward a Phase 3 clinical trial of their treatment for non-small cell lung cancer, and Daiichi Sankyo is filing a Special Protocol Assessment with the FDA to guide the design of the trial.

Chili peppers come with blood pressure benefits

August 3, 2010 10:40 am | by EurekAlert | News | Comments

(Cell Press) For those with high blood pressure, chili peppers might be just what the doctor ordered, according to a study reported in the August issue of Cell Metabolism, a Cell Press publication. While the active ingredient that gives the peppers their heat -- a compound known as...

Accuray's CyberKnife G4 System Receives Shonin Approval

August 3, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif. , Aug. 3 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today it received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the CyberKnife® G4 Robotic Radiosurgery System to...

Momenta's generic drug approval aids Q2 finances

August 2, 2010 10:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Momenta Pharmaceuticals Inc. is reporting that it narrowed its loss for the second quarter in the run up to its approval for its generic drug, enoxaparin, considered an alternative to Sanofi-Aventis’ Lovenox, an injectable drug to prevent and sometimes treat blood clots in the leg.


New studies question vascular multiple sclerosis hypothesis and treatment

August 2, 2010 10:38 am | by EurekAlert | News | Comments

(Wiley-Blackwell) Two important new studies challenge the controversial hypothesis that venous congestion -- chronic cerebrospinal venous insufficiency (CCSVI) -- contributes to the development of multiple sclerosis. This theory has resulted in many MS patients receiving...

Charles River Labs sees drop in Q2 numbers

August 2, 2010 9:41 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Just days after announcing the cancellation of its planned $1.6 billion buy of China’s WuXi PharmaTech (Cayman) Inc., Charles River Laboratories International Inc. reports that it numbers for the second quarter of 2010 were down versus the same period last year.

Disparities in cardiovascular risk based more on socioeconomic status than race, ethnicity

August 2, 2010 9:41 am | by EurekAlert | News | Comments

(University of California - Los Angeles) A new study suggests that disparities in cardiovascular disease risk in the United States are due less to race or ethnicity than to socioeconomic status. The researchers found that there are large differences in risk by socioeconomic status...

Dose optimization workshop helps reduce radiation dose associated with MDCT scans

August 2, 2010 9:41 am | by EurekAlert | News | Comments

(American College of Radiology / American Roentgen Ray Society) Numerous radiology practices were able to significantly reduce the radiation dose associated with multi-detector computed tomography scans by participating in a one day dose optimization workshop provided by the Royal...

Negative effects of sleep restriction may linger after 1 night of recovery sleep

July 31, 2010 10:37 pm | by EurekAlert | News | Comments

(American Academy of Sleep Medicine) Neurobehavioral impairments such as delayed reaction times accumulated across a period of five days when sleep was restricted to less than four hours per night. Measures of alertness improved significantly after a night of recovery sleep, with...


SIDS surprise: Study finds that infant boys are more easily aroused from sleep than girls

July 31, 2010 10:37 pm | by EurekAlert | News | Comments

(American Academy of Sleep Medicine) At 2 to 4 weeks of age, the mean strength of a pulsatile air-jet stimulus that was required to induce arousal during quiet sleep was significantly lower in male infants than female infants. At 2 to 3 months of age when the SIDS risk peaks, this...

Missing Puma reveals cancer conundrum

July 31, 2010 2:37 pm | by EurekAlert | News | Comments

(Walter and Eliza Hall Institute) Walter and Eliza Hall Institute researchers in Melbourne, Australia, have made a discovery that has upended scientists' understanding of programmed cell death and its role in tumor formation.

NICE Recommends First Device Under New Technology Pathway

July 30, 2010 5:31 pm | by U.S. Food & Drug Administration | News | Comments

The UK's National Institute for Health and Clinical Excellence (NICE) has given a provisional nod to B. Braun Medical's SeQuent Please balloon catheter for use in patients with in-stent restenosis in bare metal coronary artery stents, following the recommendation of the...

30 million women to benefit from health reform law

July 29, 2010 10:37 pm | by EurekAlert | News | Comments

(Commonwealth Fund) Thirty million women will benefit from the new health reform law over the next decade, either through new or strengthened insurance coverage, according to a new report from The Commonwealth Fund. The law will stabilize and reverse the growing exposure to health...

Western diet link to ADHD

July 29, 2010 12:38 pm | by EurekAlert | News | Comments

(Research Australia) A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a "Western-style" diet in adolescents. The research findings have just been published online in the international Journal of Attention Disorders. Leader...

Vitamin D deficiency linked to arterial stiffness in black teens

July 29, 2010 4:41 am | by EurekAlert | News | Comments

(The Endocrine Society) Vitamin D deficiency is associated with arterial stiffness, a risk factor for heart disease and stroke, in black teens according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism. Black teens...

New lab test could identify imatinib resistance

July 28, 2010 10:35 pm | by EurekAlert | News | Comments

(American Association for Cancer Research) Scientists in Japan may have developed a way to accurately predict those patients who will resist treatment with imatinib, which is the standard of care for chronic myeloid leukemia.

Best hope for saving Arctic sea ice is cutting soot emissions, says Stanford researcher

July 28, 2010 2:43 pm | by EurekAlert | News | Comments

(Stanford University) Soot from the burning of fossil fuels and solid biofuels contributes far more to global warming than has been thought, according to a new Stanford study. But, unlike carbon dioxide, soot lingers only a few weeks in the atmosphere, so cutting emissions could...

Huntington's disease discovery provides new hope for treatment

July 28, 2010 2:43 pm | by EurekAlert | News | Comments

(University of Melbourne) Australian scientists have identified the behavior of the mutant protein "huntingtin" which leads to the fatal Huntington's disease providing potential targets to treat the disease, a University of Melbourne study reveals.

Current list of MAK and BAT values presented with 61 modifications and new entries

July 28, 2010 2:43 pm | by EurekAlert | News | Comments

(Deutsche Forschungsgemeinschaft) The Deutsche Forschungsgemeinschaft Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area has presented the 2010 list of MAK and BAT values containing new data on 61 substances. These values for the...

Boston Scientific launches intracranial stent

July 28, 2010 11:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Medical device manufacturer Boston Scientific Corp. today said that it has launched U.S. and European sales of its Neuroform EZ Stent System.

Molecular mechanism triggering Parkinson's disease identified in Stanford study

July 28, 2010 11:35 am | by EurekAlert | News | Comments

(Stanford University Medical Center) Scientists at the Stanford University School of Medicine have identified a molecular pathway responsible for the death of key nerve cells whose loss causes Parkinson's disease. This discovery not only may explain how a genetic mutation linked to...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.